98%
921
2 minutes
20
Proton Bragg peak irradiation has a higher ionizing density than conventional photon irradiation or the entrance of the proton beam profile. Whether targeting the DNA damage response (DDR) could enhance vulnerability to the distinct pattern of damage induced by proton Bragg peak irradiation is currently unknown. Here, we performed genetic or pharmacologic manipulation of key DDR elements and evaluated DNA damage signaling, DNA repair, and tumor control in cell lines and xenografts treated with the same physical dose across a radiotherapy linear energy transfer spectrum. Radiotherapy consisted of 6 MV photons and the entrance beam or Bragg peak of a 76.8 MeV spot scanning proton beam. More complex DNA double-strand breaks (DSB) induced by Bragg peak proton irradiation preferentially underwent resection and engaged homologous recombination (HR) machinery. Unexpectedly, the ataxia-telangiectasia mutated (ATM) inhibitor, AZD0156, but not an inhibitor of ATM and Rad3-related, rendered cells hypersensitive to more densely ionizing proton Bragg peak irradiation. ATM inhibition blocked resection and shunted more DSBs to processing by toxic ligation through nonhomologous end-joining, whereas loss of DNA ligation via XRCC4 or Lig4 knockdown rescued resection and abolished the enhanced Bragg peak cell killing. Proton Bragg peak monotherapy selectively sensitized cell lines and tumor xenografts with inherent HR defects, and the repair defect induced by ATM inhibitor coadministration showed enhanced efficacy in HR-proficient models. In summary, inherent defects in HR or administration of an ATM inhibitor in HR-proficient tumors selectively enhances the relative biological effectiveness of proton Bragg peak irradiation. SIGNIFICANCE: Coadministration of an ATM inhibitor rewires DNA repair machinery to render cancer cells uniquely hypersensitive to DNA damage induced by the proton Bragg peak, which is characterized by higher density ionization..
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260463 | PMC |
http://dx.doi.org/10.1158/0008-5472.CAN-20-2960 | DOI Listing |
Vet Parasitol
August 2025
Nano Biosciences and Nanopharmacology Division, Biomaterials and Biotechnology in Animal Health Lab, Department of Animal Health and Management, Alagappa University, Karaikudi, Tamil Nadu 630004, India. Electronic address:
In the present work, the in vitro efficacy of titanium isopropoxide, Cassia auriculata flower extract and C. auriculata-mediated titanium nanoparticles (Ca-TiO NPs) as an acaricidal drug against Rhipicephalus (Boophilus) microplus (larvae, nymph and adult) and Haemaphysalis bispinosa (adult) was evaluated. The synthesized nanomaterial was then characterized through UV, XRD, FTIR, Zeta potential and HR-TEM techniques.
View Article and Find Full Text PDFFront Oncol
August 2025
Institute of Medical Imaging and Artificial Intelligence of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Radiotherapy remains essential in breast cancer management, yet its long-term cardiotoxicity, driven primarily by radiation-induced myocardial fibrosis, threatens survivorship, particularly in left-sided tumors. Surgical refinements, including breast-conserving surgery with sentinel lymph node biopsy and total mastectomy, effectively reduce radiation fields and cardiac exposure. Intraoperative radiotherapy with lead shielding markedly lowers left anterior descending artery dose from 5.
View Article and Find Full Text PDFInt J Radiat Oncol Biol Phys
August 2025
Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA. Electronic address:
Purpose: Poly ADP ribose polymerase inhibitors (PARPi) are being combined with photon and proton radiotherapy in clinical trials. We sought to investigate mechanisms of PARPi radiosensitization at varying linear energy transfer (LET) levels after observing an extreme normal tissue response in an 18-year-old with high grade glioma without a germline alteration predictive of heightened radiosensitivity treated with veliparib and proton therapy.
Experimental Design: BRCA1/2 wild-type non-cancerous and cancerous cells were treated with PARPi plus photons or protons at the entrance (ENT, dose-averaged LET [LETd] 2.
Biomedicines
July 2025
Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung 40402, Taiwan.
: Within the range of spread-out Bragg peak (SOBP), LET (linear energy transfer) gradually increases from proton beam entrance point toward the beam exit direction. While it is expected that the change in LET would lead to correspondent change in RBE (relative biological effectiveness) on many human cell lines, the incomplete cell killing due to low LET can result in tumor recurrence. Hence, this study aimed to assess the RBE on different cancer cell lines along low-LET proton SOBP.
View Article and Find Full Text PDFPhys Med Biol
September 2025
School of Nuclear Science and Technology, Lanzhou University, Lanzhou, People's Republic of China.
In-beam positron emission tomography (PET) is a promising approach for dose monitoring in carbon-ion radiotherapy (CIRT). This study evaluated the feasibility of a dual-head PET system using lutetium-yttrium oxyorthosilicate (LYSO) scintillators and silicon photomultiplier (SiPM) detectors incorporating time-of-flight (TOF) technology to monitor carbon-ion beam dose distribution.The dual-head PET system includes four modules per head, each comprising a 12 × 12 array of LYSO crystals (4.
View Article and Find Full Text PDF